Protection Motivation Theory-Based Education for Infectious Disease Prevention in Primary Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYuzuncu Yil University

About this trial

This study aims to evaluate the effect of a Protection Motivation Theory-based educational intervention on infectious disease perception, risk awareness, and protective health behaviors among adults attending primary care services. Participants will be assigned to an intervention group or a control group. The intervention group will receive a face-to-face educational program based on Protection Motivation Theory, while the control group will continue to receive routine health services without an additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4 using validated self-report measures.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being 18 years of age or older.

Being registered with and receiving services from the family health center where the study is conducted.

Being able to communicate in Turkish.

Voluntarily agreeing to participate in the study.

Disqualifiers

Having a condition that prevents effective communication or participation in the educational intervention.

Declining to participate or withdrawing consent at any stage of the study.

Failing to complete the required pre-intervention or post-intervention assessments.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Protection Motivation Theory-Based Educational Program

    Behavioral

    Participants in the intervention group will receive a face-to-face educational program based on Protection Motivation Theory. The program will cover infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. The intervention is designed to enhance threat appraisal and coping appraisal related to infectious disease prevention and to promote protective health behaviors.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Protection Motivation Theory-Based Education GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in Communicable Diseases Risk Awareness and Protection

Communicable disease risk awareness and protection will be assessed using the Communicable Diseases Risk Awareness and Protection Scale (CDRAPS). The scale consists of 36 items rated on a 5-point Likert scale, with total scores ranging from 36 to 180. Higher scores indicate higher levels of communicable disease risk awareness and protection. Change in total score from baseline to Week 4 will be evaluated.

Time frame
Baseline and Week 4
2

Change in Perception Toward Infectious Diseases

Perception toward infectious diseases will be assessed using the Perception Scale for Infectious Diseases. The scale consists of 34 items rated on a 5-point Likert scale, with total scores ranging from 34 to 170. Higher scores indicate a more positive perception toward infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

Time frame
Baseline and Week 4
3

Change in Preventive Health Behaviors for Emerging Infectious Diseases

Preventive health behaviors will be assessed using the Turkish version of the Emerging Infectious Diseases Preventive Health Behavior Scale (EID-PHB-T-30). The scale consists of 30 items rated on a 5-point Likert scale, with total scores ranging from 30 to 150. Higher scores indicate higher levels of preventive health behaviors against emerging infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

Time frame
Baseline and Week 4

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: